Shaily Engineering Plastics Share Price Surges Over 5% in Stock Market Today After ₹423 Crore Pharma Order Win

Shaily Engineering Plastics Share Price Surges Over 5% in Stock Market Today After ₹423 Crore Pharma Order Win

In the stock market today, one small-cap name quietly stole the spotlight — Shaily Engineering Plastics share price jumped sharply after a major business update.

Investors reacted quickly. The momentum was visible right from early trade.

Let’s break it down calmly. No noise. Just facts.

Market Performance: Strong Reaction in Stock Market Today

The Shaily Engineering Plastics share price rallied over 5% in early trading on Thursday.

  • The stock climbed as much as 5.7%
  • It touched an intraday high of ₹2,049.75 per share
  • The move was recorded on the BSE

For a small-cap stock, a 5%+ move in a single session reflects strong market sentiment. Especially when the trigger is a confirmed business order.

In the broader stock market today, such sharp reactions typically signal confidence in revenue visibility.

Open a free demat accountMain News: ₹423 Crore Order Secured for 4 Years

The big driver behind the rally?

Shaily Engineering Plastics announced it has secured a long-term order.

Here are the key financial details:

  • Order value: Approximately ₹423 crore
  • Client: A large domestic pharmaceutical company
  • Product: Pen injectors
  • Duration: 4 years
  • Disclosure date: February 25 (regulatory filing)

This is not a short-term supply deal. It’s a multi-year commitment. That brings revenue clarity for four financial years.

Pen injectors are precision healthcare components. Long-term supply contracts in this segment typically ensure steady volume execution.

That’s what the market responded to.

Company Details: India’s Largest Exporter in Its Segment

Shaily Engineering Plastics is positioned as India’s largest exporter of plastics components.

Its manufacturing footprint includes:

  • 7 facilities
  • Over 200 molding machines
  • Capacity range: 35 tons to 1,000 tons

Scale matters in plastics manufacturing. Larger molding capacity allows flexibility across industries.

The company operates in precision plastic components. Healthcare remains an important vertical.

Financial Performance: Q3FY26 Numbers in Focus

Along with the order win, recent quarterly performance provides context.

Revenue Growth

  • Q3FY26 consolidated revenue: ₹250.5 crore
  • Q3FY25 revenue: ₹197.6 crore
  • Year-on-year growth: 27%

A 27% growth rate shows strong operational momentum before this new order contribution even begins.

Net Profit Growth

  • Q3FY26 net profit: ₹37.4 crore
  • Q3FY25 net profit: ₹25.2 crore
  • Year-on-year growth: 48%

Profit growth at 48% suggests operational efficiency and cost control.

EBITDA Performance

  • Q3FY26 EBITDA: ₹66.4 crore
  • Q3FY25 EBITDA: ₹46.3 crore
  • Growth: 43% YoY

EBITDA Margins

  • Q3FY26 margin: 26.5%
  • Q3FY25 margin: 23.4%
  • Expansion: 310 basis points

Margin expansion alongside revenue growth signals improved operating leverage.

In the stock market today, such margin improvement often strengthens investor confidence.

Shaily Engineering Plastics Share Price History

Short-term correction. Long-term strength.

Here’s how the Shaily Engineering Plastics share price has performed:

  • 3 months: Down 24%
  • 6 months: Down 7%
  • 1 year: Up 32%
  • 2 years: Up 283%
  • 5 years: Up 980%

The stock has delivered multibagger returns over longer time frames.

At the same time, recent months saw some correction. The new ₹423 crore order has brought fresh attention.

Why the Market Reacted?

Let’s connect the dots.

  • Confirmed ₹423 crore order visibility
  • 4-year revenue horizon
  • Strong Q3FY26 growth numbers
  • EBITDA margin expansion to 26.5%
  • Structured healthcare order pipeline

In the stock market today, investors reward visibility and scale. This announcement checks both boxes.

But the data speaks for itself — no assumptions, no projections.

Summary: What This Means in Stock Market Today?

The rally in Shaily Engineering Plastics share price was driven by fundamentals, not speculation.

  • Multi-year pharma order worth ₹423 crore
  • Revenue growth of 27% in Q3FY26
  • Net profit growth of 48%
  • EBITDA margin improved by 310 bps
  • Long-term share price return of 980% in five years

In the broader stock market today, small-cap movements often reflect confidence in business execution. This spike follows a clear corporate update.

As always, markets respond fast to visible numbers.

And this time, the numbers were strong enough to move the stock.

Source: Livemint

Download the Samco Trading App

Get the link to download the app.

Samco Fast Trading App

Leave A Comment?